Drugmaker Questioned for Nearly Tripling Price of Potential COVID-19 Drug

The chair of a House of Representatives committee and a fellow Democratic committee member on Monday urged Jaguar Health Inc. to reverse recent price hikes of a drug that could be used to treat side effects in COVID-19 patients and …

from News – Insurance Journal